Sun Pharmaceutical Industries Limited (NSEI:SUNPHARMA) agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million on February 20, 2024. The transaction is expected to complete by the end of February 2024 and is subject fulfilment of certain conditions.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,594 INR | +0.95% |
|
+0.79% | +26.58% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.58% | 45.33B | |
+38.49% | 25.36B | |
+27.75% | 16.7B | |
+20.89% | 14.59B | |
+72.03% | 14.26B | |
-0.05% | 6.79B | |
-10.35% | 6.67B | |
+13.07% | 5.62B | |
-8.87% | 5.73B | |
+35.45% | 5.02B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited agreed to acquire 16.33% stake in Surgimatix, Inc for $3.1 million.